1. Signaling Pathways
  2. Immunology/Inflammation
  3. PD-1/PD-L1


Programmed death-1 (PD-1) is a receptor on T cells that has been shown to suppress activating signals from the T cell receptor when bound by either of its ligands, Programmed death-ligand 1 (PD-L1) or PD-L2. When PD-1 expressing T cells contact cells expressing its ligands, functional activities in response to antigenic stimuli, including proliferation, cytokine secretion, and cytotoxicity are reduced. PD-1/PD-Ligand interactions down regulate immune responses during resolution of an infection or tumor, or during the development of self tolerance.

Interference with the PD-1/PD-L1 interaction has also shown enhanced T cell activity in chronic infection systems. Chronic lymphocytic chorio meningitis virus infection of mice also exhibits improved virus clearance and restored immunity with blockade of PD-L1.

In addition to enhancing immunologic responses to chronic antigens, blockade of the PD-1/PD-L1 pathway has also been shown to enhance responses to vaccination, including therapeutic vaccination in the context of chronic infection。

PD-1/PD-L1 相关产品 (14):

Cat. No. Product Name Effect Purity
  • HY-19745
    BMS-202 Inhibitor 99.37%
    BMS-202 是 PD-1/PD-L1 相互作用抑制剂,IC50 值为 18 nM,主要用于抗癌研究。
  • HY-19991
    BMS-1 Inhibitor 99.61%
    BMS-1 是 PD-1/PD-L1 蛋白质/蛋白质相互作用的抑制剂,IC50 为 6 到 100 nM。
  • HY-P9904
    Atezolizumab Inhibitor 98.98%
    Atezolizumab 是一种人源化单克隆抗体 IgG1,抵抗程序性死亡因子配体1 (PD-L1),用于癌症研究。
  • HY-P9903
    Nivolumab Inhibitor 98.56%
    Nivolumab 是一种 PD-1 抗体类抑制剂,用于晚期(转移性)非小细胞肺癌的研究。
  • HY-101093
    PD-1-IN-1 Inhibitor 98.48%
    PD-1-IN-1是PD-1的抑制剂, 来自专利WO 2015033299 A1,化合物实例4。
  • HY-101097A
    PD-1-IN-17 TFA Inhibitor
    PD-1-IN-17 TFA 是一种有效的程序性细胞死亡-1 (PD-1) 抑制剂,详细信息请参考专利文献 WO2015033301A1 中的化合物 12,浓度为 100 nM 时抑制 92% 脾细胞增殖。
  • HY-101097
    PD-1-IN-17 Inhibitor
    PD-1-IN-17 是一种有效的程序性细胞死亡-1 (PD-1) 抑制剂,详细信息请参考专利文献 WO2015033301A1 中的化合物 12,浓度为 100 nM 时抑制 92% 脾细胞增殖。
  • HY-101093B
    PD-1-IN-20 Inhibitor
    PD-1-IN-20 是 PD-1 的抑制剂。
  • HY-P9902
    Pembrolizumab Inhibitor 98.56%
    Pembrolizumab 是一种人源化抗体,为 PD-1 的抑制剂,用于癌症免疫的研究。
  • HY-108730
    Avelumab Inhibitor
    Avelumab 是一个人 IgG1 抗 PD-L1 单克隆抗体,具有潜在的抗体依赖性细胞介导的细胞毒性作用。
  • HY-102011
    BMS-1166 Inhibitor 99.79%
    BMS-1166 是 PD-1/PD-L1 相互作用的有效抑制剂,其 IC50 值为 1.4 nM。
  • HY-B0333
    Sulfamethizole Inhibitor 99.71%
  • HY-B1387
    Sulfamethoxypyridazine Inhibitor 99.01%
    Sulfamethoxypyridazine是一种长效磺胺类药物, 用于治疗疱疹性皮炎。
  • HY-101098
    PD-1-IN-18 Inhibitor
    PD-1-IN-18 是 PD1 信号通路抑制剂,是一种免疫调节剂。
Isoform Specific Products

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

金洋彩票平台 宝博彩票平台 杏彩彩票平台 完美彩票 五百万彩票 乐彩客平台 我中啦彩票平台 网易彩票 网易彩票 众赢彩票平台